Pharma Now Podcast Features Biocon Biologics’ Regulatory Affairs Head On India’s Role In Global Vaccine And Biosimilar Exports

Pharma Now has released a new podcast episode featuring Varma Bhupatiraju, Vice President of Regulatory Affairs at Biocon Biologics. In this insightful conversation, Mr. Bhupatiraju reflects on his 22+ years in regulatory affairs, spanning vaccines, biosimilars, and pharmaceuticals across India and global markets.

He explains the pivotal role of regulatory professionals in bridging pharma companies with agencies like CDSCO and the US FDA—handling approvals, inspections, documentation, and compliance. He highlights the complexity of vaccine approvals, which involve extensive preclinical and clinical trials unlike simpler generics that only require bioequivalence studies.

The episode also explores the shift toward advanced vaccine testing methods, such as immunochemical and molecular techniques, which are reducing reliance on animal testing and improving accuracy. Mr. Bhupatiraju notes how the COVID-19 pandemic fast-tracked approvals and introduced emergency pathways, potentially paving the way for quicker future drug authorizations.

With improved regulatory systems and strong manufacturing capabilities, India is well-positioned to become a global supplier of vaccines and biosimilars. Mr. Bhupatiraju underscores the importance of ethics, quality by design, and continuous learning for young pharma professionals, emphasizing that working in this field is a responsibility to improve lives.

Listen now to gain valuable insights into the evolving regulatory landscape and India’s growing global pharmaceutical presence—available on Pharma Now’s YouTube channel.